IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PELOSI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.147
NA - Nord America 9.149
AS - Asia 8.822
SA - Sud America 843
AF - Africa 162
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 8
Totale 32.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.895
DE - Germania 5.220
GB - Regno Unito 2.936
SG - Singapore 2.779
CN - Cina 2.672
IT - Italia 1.224
SE - Svezia 880
RU - Federazione Russa 845
HK - Hong Kong 730
VN - Vietnam 703
BR - Brasile 595
FR - Francia 456
IN - India 441
TR - Turchia 366
IE - Irlanda 347
UA - Ucraina 345
KR - Corea 312
BD - Bangladesh 257
FI - Finlandia 251
NL - Olanda 243
EU - Europa 172
CA - Canada 171
JP - Giappone 134
CO - Colombia 116
ID - Indonesia 114
PL - Polonia 85
DK - Danimarca 52
AU - Australia 49
ES - Italia 47
IQ - Iraq 46
AR - Argentina 44
MX - Messico 40
GR - Grecia 38
AT - Austria 34
ZA - Sudafrica 33
BE - Belgio 29
TH - Thailandia 26
PH - Filippine 25
PK - Pakistan 25
SA - Arabia Saudita 24
EC - Ecuador 23
MA - Marocco 20
RO - Romania 20
CH - Svizzera 19
VE - Venezuela 19
DZ - Algeria 17
MY - Malesia 17
UZ - Uzbekistan 16
NP - Nepal 15
PE - Perù 15
PT - Portogallo 15
AE - Emirati Arabi Uniti 13
CI - Costa d'Avorio 13
IL - Israele 12
EG - Egitto 11
ET - Etiopia 11
NO - Norvegia 11
TN - Tunisia 11
JO - Giordania 10
KE - Kenya 9
LB - Libano 9
CL - Cile 8
HN - Honduras 8
PY - Paraguay 8
UY - Uruguay 8
CR - Costa Rica 7
IR - Iran 7
KG - Kirghizistan 7
TW - Taiwan 7
AZ - Azerbaigian 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
KH - Cambogia 6
KZ - Kazakistan 6
OM - Oman 6
HU - Ungheria 5
SN - Senegal 5
SR - Suriname 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
LK - Sri Lanka 4
NI - Nicaragua 4
PA - Panama 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BB - Barbados 3
CG - Congo 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 32.291
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 4.094
Southend 2.660
Singapore 1.626
Chandler 678
Ashburn 675
Hong Kong 668
San Jose 635
Seattle 576
Beijing 545
Milan 437
Princeton 411
Dublin 342
Wilmington 329
Dallas 326
Fairfield 310
Council Bluffs 306
Jacksonville 269
Munich 249
Los Angeles 229
Nanjing 199
Bengaluru 196
Woodbridge 189
Ho Chi Minh City 177
Lauterbourg 177
Redmond 175
Hanover 171
Des Moines 159
Hanoi 149
Santa Clara 146
Houston 142
Buffalo 136
Ann Arbor 135
Mountain View 135
Moscow 127
Guangzhou 123
Shanghai 121
Boardman 120
New York 118
Sakarya 114
Somerville 114
Hefei 109
Dearborn 106
Chicago 102
Bogotá 100
Serra 98
Tokyo 97
Andover 94
Cambridge 88
Columbus 83
Berlin 81
Jinan 77
The Dalles 76
Tianjin 76
Jakarta 71
Helsinki 70
Warsaw 69
Shenyang 68
Nanchang 67
Cangzhou 64
Phoenix 64
Shenzhen 64
Ottawa 61
Dong Ket 60
São Paulo 60
Toronto 48
Redwood City 47
Hangzhou 44
Istanbul 43
Kiez 42
Salt Lake City 42
San Diego 41
Fuzhou 38
Hebei 38
Athens 35
Changsha 34
Seoul 34
Da Nang 32
Jiaxing 32
Sunnyvale 32
Eitensheim 31
Nuremberg 29
Haiphong 28
Rome 28
Zhengzhou 28
Elk Grove Village 26
London 26
Bühl 25
Turin 25
Rio de Janeiro 24
Falls Church 22
Hamburg 21
Atlanta 20
Verona 20
Washington 20
Baghdad 19
Amsterdam 18
Brussels 18
Kunming 18
Orem 18
Taiyuan 18
Totale 21.457
Salva come PNG Salva come JPEG
Nome #
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms 508
Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations 383
Prognostic role of lymph node involvement in lung metastasectomy 355
Long-term outcomes of a pilot CT screening for lung cancer 342
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers 342
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors 326
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status 299
5 '-Nucleotidase (CN-II) emerges as a new predictive biomarker of response in the gemcitabine-cisplatin treatment of non-small cell lung cancer 298
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer 294
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung 283
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal 267
Challenging lung carcinoma with coexistent δnp63/p40 and thyroid transcription factor-1 labeling within the same individual tumor cells 266
Comorbidities in idiopathic pulmonary fibrosis : an underestimated issue 266
Annual or biennial CT screening versus observation in heavy smokers : 5-year results of the MILD trial 264
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors 256
A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer 254
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 250
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor 245
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare 245
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer 244
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer 238
Alterations of the Notch pathway in lung cancer 237
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma 235
Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules 232
Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S) : a proof for artifact 230
Localised thoracic sarcomas : outcome improvement over time at a single institution 227
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology 226
Diagnosis and management of typical and atypical lung carcinoids 226
Primary thoracic synovial sarcoma : factors affecting long-term survival 224
3q26 amplification and polysomy of chromosome 3 in squamous cell lesions of the lung : a fluorescence in situ hybridization study 219
Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type 218
Clinical implications of lung neuroendocrine neoplasm classification 217
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileum 216
Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer : A baseline and 2-year repeat study 215
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening 212
Genomic characterization of asymtpomatic CT-detected lung cancers 211
Survival rate of patients who develop cancer in rectal stump after colectomy and IRA in FAP patients 211
Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors 211
Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk 210
Screening-detected lung cancers: is systematic nodal dissection always essential? 207
Lung cancer screening with low-dose computed tomography : A non-invasive diagnostic protocol for baseline lung nodules 205
Genomic characterization of asymtpomatic CT-detected lung cancers 205
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program 203
Assessment of overdiagnosis in CT screening for lung cancer 203
Challenging diagnosis of an unusual solitary pulmonary nodule 202
Eriotinib-induced breast cancer regression 202
Giant Secondary Overgrowth of Type-1 Pulmonary Cystic Airway Malformation Upon Development of Anaplastic Lymphoma Kinase–Rearranged Adenocarcinoma 201
Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung 198
Recent advances in the molecular landscape of lung neuroendocrine tumors 198
Pulmonary hypertension and chronic lung disease : where are we headed? 198
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression 197
High-resolution CT in smoking-related interstitial lung diseases 193
Cetuximab for colorectal cancer 191
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation 191
Surgical damage control treatment of a large retroperitoneal liposarcoma encasing a horseshoe kidney 191
Classification of pulmonary neuroendocrine tumors: New insights 191
Synchronous bilateral lung carcinoid tumors: a rare entity? 190
Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer 189
Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women 188
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer 188
Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series 188
Structural lung damage after chemotherapy, fact or fiction? 185
Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib 184
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 184
Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I nonsmall cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung 183
A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme 183
Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer 182
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy? 182
Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules 181
Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib 179
Lung cryobiopsy for the diagnosis of interstitial lung diseases: A series contribution to a debated procedure 179
CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung : relevance to prognosis in a subset of adenocarcinoma patients 178
Alteration of the E-cadherin/β-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids 177
Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis 177
miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas 176
Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis : preliminary results 174
Randomized Dose-Ranging Trial of Tamoxifen at Low Doses in Hormone Replacement Therapy Users 173
Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature 172
Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer 171
Study of inorganic particles, fibers, and asbestos bodies by variable pressure scanning electron microscopy with annexed energy dispersive spectroscopy and micro-Raman spectroscopy in thin sections of lung and pleural plaque 170
Poorly differentiated synovial sarcoma of the vagina : first reported case with immunohistochemical, molecular and ultrastructural data 168
Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors : immunohistochemical study and gene expression analysis 168
Results of annual screening of lung cancer with low dose computed tomography in 5,000 high-risk individuals 168
Therapy-Oriented large scale gene expression analysis In lung carcinoids 168
The classification of lung carcinoma: time to change the morphology-based approach? 167
CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung : a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas 164
Invited Commentary 164
Detecting lung cancer in plasma with the use of multiple genetic markers 163
Treatment of pulmonary metastases from primary intraosseous odontogenic carcinoma 162
Benign hyperplastic mesothelial cells in lymph node 162
Lung cancer risk prediction to select smokers for screening CT : a model based on the Italian COSMOS trial 162
Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours 161
CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients 161
ΔNp63 (p40) distribution inside lung cancer : a driver biomarker approach to tumor characterization 160
Expression of gemcitabine and cisplatin-related genes according to histology and stage in non-small-cell lung cancer (NSCLC) 159
Structural lung damage after chemotherapy. fact or fiction? 156
Langerhans' cell histiocytosis 155
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer 155
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung 155
Prognostic role of lymph node involvement in lung metastasectomy 153
Totale 21.142
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021760 0 0 0 0 0 0 0 0 0 0 558 202
2021/20221.937 87 60 46 84 160 115 225 141 151 253 138 477
2022/20232.424 339 192 188 271 297 514 41 172 207 27 114 62
2023/20243.921 49 110 64 39 237 150 581 533 267 539 647 705
2024/20255.345 609 650 467 584 258 160 176 473 233 261 361 1.113
2025/20268.460 793 486 936 574 819 615 1.135 540 1.121 730 711 0
Totale 33.786